Enzo Biochem, Inc. (ENZ)

Enzo Biochem Statistics

Total Valuation

Enzo Biochem has a market cap or net worth of $34.22 million. The enterprise value is -$10.25 million.

Market Cap	34.22M
Enterprise Value	-10.25M

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025, after market close.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	Nov 15, 2024

Share Statistics

Enzo Biochem has 52.24 million shares outstanding. The number of shares has increased by 3.82% in one year.

Current Share Class	52.24M
Shares Outstanding	52.24M
Shares Change (YoY)	+3.82%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	20.30%
Owned by Institutions (%)	19.92%
Float	36.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.11
Forward PS	n/a
PB Ratio	0.72
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.07.

Current Ratio	2.55
Quick Ratio	2.20
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-53.36

Financial Efficiency

Return on equity (ROE) is -11.83% and return on invested capital (ROIC) is -9.94%.

Return on Equity (ROE)	-11.83%
Return on Assets (ROA)	-7.24%
Return on Capital (ROIC)	-9.94%
Revenue Per Employee	$222,897
Profits Per Employee	-$167,926
Employee Count	136
Asset Turnover	0.33
Inventory Turnover	2.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.21% in the last 52 weeks. The beta is 0.80, so Enzo Biochem's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	-53.21%
50-Day Moving Average	0.91
200-Day Moving Average	1.07
Relative Strength Index (RSI)	30.88
Average Volume (20 Days)	154,054

Short Selling Information

The latest short interest is 421,877, so 0.81% of the outstanding shares have been sold short.

Short Interest	421,877
Short Previous Month	477,483
Short % of Shares Out	0.81%
Short % of Float	1.16%
Short Ratio (days to cover)	2.80

Income Statement

In the last 12 months, Enzo Biochem had revenue of $30.31 million and -$22.84 million in losses. Loss per share was -$0.45.

Revenue	30.31M
Gross Profit	13.46M
Operating Income	-10.51M
Pretax Income	44.73M
Net Income	-22.84M
EBITDA	-9.19M
EBIT	-10.51M
Loss Per Share	-$0.45

Balance Sheet

The company has $47.74 million in cash and $3.27 million in debt, giving a net cash position of $44.47 million or $0.85 per share.

Cash & Cash Equivalents	47.74M
Total Debt	3.27M
Net Cash	44.47M
Net Cash Per Share	$0.85
Equity (Book Value)	47.66M
Book Value Per Share	0.91
Working Capital	36.26M

Cash Flow

In the last 12 months, operating cash flow was -$21.88 million and capital expenditures -$739,000, giving a free cash flow of -$22.61 million.

Operating Cash Flow	-21.88M
Capital Expenditures	-739,000
Free Cash Flow	-22.61M
FCF Per Share	-$0.43

Margins

Gross margin is 44.39%, with operating and profit margins of -34.67% and -75.34%.

Gross Margin	44.39%
Operating Margin	-34.67%
Pretax Margin	-23.79%
Profit Margin	-75.34%
EBITDA Margin	-30.32%
EBIT Margin	-34.67%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $0.40, which amounts to a dividend yield of 61.07%.

Dividend Per Share	$0.40
Dividend Yield	61.07%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-3.82%
Shareholder Yield	57.25%
Earnings Yield	-66.74%
FCF Yield	-66.08%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 21, 2004. It was a forward split with a ratio of 1.05:1.

Last Split Date	Oct 21, 2004
Split Type	Forward
Split Ratio	1.05:1

Scores

Enzo Biochem has an Altman Z-Score of -3.69 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.69
Piotroski F-Score	4